胃癌与肠道菌群关系的研究进展
Research Progress on the Relationship between Gastric Cancer and Intestinal Flora
DOI: 10.12677/ACM.2021.118513, PDF,  被引量   
作者: 刘 瞳*:青海大学研究生院,青海 西宁;杨金煜#:青海省人民医院,青海 西宁
关键词: 胃癌肠道菌群幽门螺杆菌Gastric Cancer Intestinal Flora Helicobacter pylori
摘要: 近年来,随着众多高新科学技术的发展和应用,人们对消化系统的肿瘤有了长足的认知。大量的研究证明,肠道菌群的失衡和胃肠肿瘤的发生之间存在着错综复杂的关系。越来越多的研究表明,与正常人群相比,胃癌患者肠道菌群的含量及群落构成比例等各方面的差异不尽相同,胃癌患者的肠道微生物群落之间存在着丰度的转变。本文从胃癌与肠道菌群之间的关系,对二者之间的研究关系及进展作一相关综述,旨在为胃癌患者的预防、临床治疗及预后生存质量等有关方面提供一些新的思路及方法。
Abstract: In recent years, with the development and application of many high and new sciences and technologies, people have a considerable understanding of digestive system tumors. A large number of studies have proved that there is a complex relationship between the imbalance of intestinal flora and the occurrence of gastrointestinal tumors. More and more studies have shown that compared with the normal population, the content and composition of intestinal microflora in patients with gastric cancer are different. There is a change in the abundance of intestinal microflora in patients with gastric cancer. Based on the relationship between gastric cancer and intestinal flora, this paper reviewed the research relationship and progress between them, aiming to provide some new ideas and methods for the prevention, clinical treatment, prognosis and quality of life of gastric cancer patients.
文章引用:刘瞳, 杨金煜. 胃癌与肠道菌群关系的研究进展[J]. 临床医学进展, 2021, 11(8): 3517-3522. https://doi.org/10.12677/ACM.2021.118513

参考文献

[1] Moris, D., Schizas, D., Michalinos, A., et al. (2017) The Expression of Claudin-4 in Gastric Cancer Tissue: A Single Center Experience. Journal of BUON, 22, 403-409.
[2] Nikniaz, Z., Somi, M.H., Nagashi, S. and Nikniaz, L. (2017) Impact of Early Enteral Nutrition on Nutritional and Immu-nological Outcomes of Gastric Cancer Patients Under-Going Gastrostomy: A Systematic Review and Meta-Analysis. Nutrition and Cancer, 69, 693-701. [Google Scholar] [CrossRef] [PubMed]
[3] Mayne, S.T., Risch, H.A., Dubrow, R., et al. (2001) Nutrient Intake and Risk of Subtypes of Esophageal and Gastric cancer. Cancer Epidemiology Biomarkers and Prevention, 10, 1055-1062.
[4] Matson, V. and Chervin, C.G. and Thomas, F. (2020) Cancer and the Microbiome: Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gastroenterology, 160, 600-613. [Google Scholar] [CrossRef] [PubMed]
[5] Bhandari, A. and Crowe, S.E. (2012) Helicobacter Pylori in Gastric Malignancies. Current Gastroenterology Reports, 14, 489-496. [Google Scholar] [CrossRef] [PubMed]
[6] Plummer, M., de Martel, C., Vignat, J., et al. (2016) Global Burden of Cancers Attributable to Infections in 2012: A Synthetic Analysis. Lancet Glob Health, 4, e609-e616. [Google Scholar] [CrossRef
[7] Yu, G.Q., et al. (2017) Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients. Frontiers in Cellular and Infection Microbiology, 7, 302. [Google Scholar] [CrossRef] [PubMed]
[8] Gao, J.-J., et al. (2018) Association between Gut Microbiota and Helicobacter Pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer. Frontiers in Cellular and Infection Microbiology, 8, 202. [Google Scholar] [CrossRef] [PubMed]
[9] Meng, C., Bai, C., Brown, T.D., et al. (2018) Human Gut Microbiota and Gastrointestinal Cancer. Genomic Proteomics Bioinformatics, 16, 33-49. [Google Scholar] [CrossRef] [PubMed]
[10] Wan, Y., Yuan, J., Li, J., et al. (2020) Unconjugated and Secondary Bile Acid Profiles in Response to Higher-Fat, Lower-Carbohydrate Diet and Associated with Related Gut Microbiota: A 6-Month Randomized Controlled-Feeding Trial. Clinical Nutrition, 39, 395-404. [Google Scholar] [CrossRef] [PubMed]
[11] Kuugbee, E.D., Shang, X., Gamallat, Y., et al. (2016) Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer. Digestive Diseases and Sciences, 61, 2908-2920. [Google Scholar] [CrossRef] [PubMed]
[12] Reid, G., Sanders, M.E., Gaskins, H.R., Gibson, G.R., Mercenier, A., Rastall, R., Roberfroid, M., Rowland, I., Cherbut, C. and Klaenhammer, T.R. (2003) New Scientific Paradigms for Probiotics and Prebiotics. Journal of Clinical Gastroenterology, 37, 105-118. [Google Scholar] [CrossRef] [PubMed]
[13] Francesco, R., Michele, L. and Antonella, O. (2014) Probiotics against Neoplastic Transformation of Gastric Mucosa: Effects on Cell Proliferation and Polyamine Metabolism. World Journal of Gastroenterology, 20, 13258-13272. [Google Scholar] [CrossRef] [PubMed]
[14] Boursi, B., Mamtani, R., Haynes, K., et al. (2015) Recurrent Antibiotic Exposure May Promote Cancer Formation-Another Step in Understanding the Role of the Human Microbiota? European Journal of Cancer, 51, 2655-2664. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, C.Z., Zhang, C.F., Chen, L., et al. (2015) Colon Cancer Chemopreventive Effects of Baicalein, an Active Enteric Microbiome Metabolite from Baicalin. International Journal of Oncology, 47, 1749-1758. [Google Scholar] [CrossRef] [PubMed]
[16] Zam, W. (2018) Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence. Journal of Nutrition and Metabolism, 2018, Article ID: 1367984. [Google Scholar] [CrossRef] [PubMed]
[17] 薛志刚. 免疫营养干预影响肠道微生态及胃肠肿瘤结局基础与临床初探[D]: [博士学位论文]. 北京: 北京协和医学院, 2020.
[18] Gui, Q.F., Lu, H.F., Zhang, C.X., et al. (2015) Well-Balanced Commensal Microbiota Contributes to Anti-Cancer Response in a Lung Cancer Mouse Model. Genetics and Molecular Research, 14, 5642-5651. [Google Scholar] [CrossRef
[19] Miyata, H., Yano, M., Yasuda, T., et al. (2017) Randomized Study of the Clinical Effects of Omega-3 Fatty Acid-Containing Enteral Nutrition Support during Neoadjuvant Chemo-Therapy on Chemotherapy-Related Toxicity in Patients with Esophageal Cancer. Nutrition, 33, 204-210. [Google Scholar] [CrossRef] [PubMed]
[20] Zong, L., Li, H.Y. and Li, S.H. (2019) Effects of Neoadjuvant Chemotherapy Combined with Enteral Nutrition on Perioperative Immunity, Inflammation and Intestinal Flora in Gastric Cancer Patients. Official Journal of the Balkan Union of Oncology, 24, 1113-1119.
[21] Nakanoko, T., Kakeji, Y., Ando, K., et al. (2015) Assessment of Surgical Treatment and Postoperative Nutrition in Gastric Cancer Patients Older than 80 Years. Anticancer Research, 35, 511-515.
[22] Li, Y., Tinoco, R., Elmén, L., et al. (2019) Gut Microbiota Dependent Anti-Tumor Immunity Restricts Melanoma Growth in Rnf5-/-Mice. Nature Communications, 10, Article No. 1492. [Google Scholar] [CrossRef] [PubMed]
[23] Vétizou, M., Pitt, J.M., Daillère, R., et al. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084. [Google Scholar] [CrossRef] [PubMed]
[24] Schinzari, G., Cassano, A., Orlandi, A., Basso, M. and Barone, C. (2014) Targeted Therapy in Advanced Gastric Carcinoma: The Future Is Beginning. Current Medicinal Chemistry, 21, 1026-1038. [Google Scholar] [CrossRef] [PubMed]
[25] Park, D.J., Park, Y.S., Ahn, S.H. and Kim, H.H. (2017) Laparoscopic Proximal Gastrectomy as a Surgical Treatment for Upper Third Early Gastric Cancer. Korean Journal of Gastroenterology, 70, 134-140.
[26] Qiu, M., Zhou, Y.X., Jin, Y., et al. (2015) Nutrition Support Can Bring Survival Benefit to High Nutrition Risk Gastric Cancer Patients Who Received Chemotherapy. Support Care Cancer, 23, 1933-1939. [Google Scholar] [CrossRef] [PubMed]
[27] Coleman, M.P., Estève, J., Damiecki, P., Arslan, A. and Renard, H. (1993) Trends in Cancer Incidence and Mortality. IARC Scientific Publications, 121, 1-806.
[28] Bornschein, J., Rokkas, T., Selgrad, M. and Malfertheiner, P. (2011) Gastric Cancer: Clinical Aspects, Epidemiology and Molecular Back-Ground. Helicobacter, 16, 45-52. [Google Scholar] [CrossRef] [PubMed]
[29] Tlaskalová-Hogenová, H., Stěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., Klimešová, K., Přibylová, J., Bártová, J., Sanchez, D., Fundová, P., Borovská, D., Srůtková, D., Zídek, Z., Schwarzer, M., Drastich, P. and Funda, D.P. (2011) The Role of Gut Micro-Biota (Commensal Bacteria) and the Mucosal Barrier in the Pathogenesis of Inflammatory and Autoimmune Diseases and Cancer: Contribution of Germ-Free and Gnotobiotic Animal Models of Human Diseases. Cellular & Molecular Immunology, 8, 110-120. [Google Scholar] [CrossRef] [PubMed]
[30] 何力宏, 任龙飞, 吴永娜, 任程晖, 何咏霖, 张磊. 肠道菌群与胃肠肿瘤关系的研究进展[J]. 中国微生态学杂志, 2020, 32(10), 1215-1218, 1228.
[31] Nikniaz, Z., Somi, M.H., Nagashi, S. and Nikniaz, L. (2017) Impact of Early Enteral Nutrition on Nutritional and Immu-nological Outcomes of Gastric Cancer Patients Under-going Gastrostomy: A Systematic Review and Meta-Analysis. Nutrition and Cancer, 69, 693-701. [Google Scholar] [CrossRef] [PubMed]